SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001085037-21-000069
Filing Date
2021-08-18
Accepted
2021-08-18 12:34:06
Documents
8
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6kjune20201.htm 6-K 8042
2 NEWS RELEASE DATED JUNE 3, 2021 ex99_1.htm EX-99.1 6957
3 MATERIAL CHANGE REPORT DATED JUNE 3, 2021 ex99_2.htm EX-99.2 60404
4 NEWS RELEASE DATED JUNE 15, 2021 ex99_3.htm EX-99.3 7067
5 MATERIAL CHANGE REPORT DATED JUNE 16, 2021 ex99_4.htm EX-99.4 6319
6 image00001.jpg GRAPHIC 3317
7 image00003.jpg GRAPHIC 4674
8 image00004.jpg GRAPHIC 2543
  Complete submission text file 0001085037-21-000069.txt   104989
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 211186199
SIC: 2836 Biological Products, (No Diagnostic Substances)